OABI
OmniAb, Inc.
Key Financials
Operating Income
$-68969000
↑ 7.4%
Net Income
$-64779000
↓ 4.4%
Revenue
$18.7M
↓ 29.3%
EPS (Diluted)
$-0.57
↑ 6.6%
Cash & Equivalents
$25.5M
↓ 7.5%
Total Liabilities
$33.9M
↓ 10.7%
Shareholders' Equity
$267.0M
↓ 7.2%
Total Assets
$300.9M
↓ 7.6%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 4 | 6/18/2026 | View on SEC |
| 4 | 6/18/2026 | View on SEC |
| 4 | 6/18/2026 | View on SEC |
| 4 | 6/18/2026 | View on SEC |
| 4 | 6/18/2026 | View on SEC |
| 4 | 6/18/2026 | View on SEC |
| 8-K | 6/18/2026 | View on SEC |
| 10-Q | 5/7/2026 | View on SEC |
| 8-K | 5/7/2026 | View on SEC |
| ARS | 4/29/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | OABI |
| Company Name | OmniAb, Inc. |
| CIK | 1846253 |
| Sector | Services-Commercial Physical & Biological Research |
| Industry | Emerging growth company |
| Exchange | Nasdaq |
| SIC Code | 8731 |
| SIC Description | Services-Commercial Physical & Biological Research |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 510-250-7800 |